Conatus Pharmaceuticals (CNAT) null Earnings

14MayConfirmed
Sep 13
Nov 13
Mar 14
May 14
-0.37
-0.19
-0.02
0.16

Details

Expected EPS
N/A
Actual EPS
-0.3402
Surprise EPS
-0.34
Surprise Percent
+∞%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.3402 per share for .

0 Comments

Share your thoughts